ID   BrE2
AC   CVCL_XB10
SY   BrE-2; HB BrE-2
DR   CCRID; 4201PAT-CCTCC00054
DR   Wikidata; Q93431541
RX   Patent=US5077220;
RX   PubMed=2365381;
RX   PubMed=7493358;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); HB-9795.
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; P15941; Human MUC1/CD227.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 06-09-19; Last updated: 21-03-23; Version: 5
//
RX   Patent=US5077220;
RA   Ceriani R.L., Peterson J.A.;
RT   "Monoclonal antibody specific to a novel glycoprotein antigen on
RT   human carcinoma cells.";
RL   Patent number US5077220, 31-Dec-1991.
//
RX   PubMed=2365381; DOI=10.1089/hyb.1990.9.221;
RA   Peterson J.A., Zava D.T., Duwe A.K., Blank E.W., Battifora H.A.,
RA   Ceriani R.L.;
RT   "Biochemical and histological characterization of antigens
RT   preferentially expressed on the surface and cytoplasm of breast
RT   carcinoma cells identified by monoclonal antibodies against the human
RT   milk fat globule.";
RL   Hybridoma 9:221-235(1990).
//
RX   PubMed=7493358;
RA   Peterson J.A., Couto J.R., Taylor M.R., Ceriani R.L.;
RT   "Selection of tumor-specific epitopes on target antigens for
RT   radioimmunotherapy of breast cancer.";
RL   Cancer Res. 55 Suppl. 23:5847s-5851s(1995).
//